Feedback
Settings

Settings

Goto Application

1. WO2022160066 - POLYMORPH OF LATREPIRDINE DIHYDROCHLORIDE

Submit observation
PermaLink
Publication Number WO/2022/160066
Publication Date 04.08.2022
International Application No. PCT/CA2022/050136
International Filing Date 31.01.2022
IPC
C07D 471/04 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/444 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
4427containing further heterocyclic ring systems
444containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone
A61P 25/28 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants
  • BIGESPAS LTD. [GB]/[GB]
  • GORINE, Boris [CA]/[CA]
Inventors
  • GORINE, Boris
  • YUROVSKAYA, Marina
Agents
  • RIDOUT & MAYBEE LLP
  • AGHA, Kazim
Priority Data
17/164,58301.02.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) POLYMORPH OF LATREPIRDINE DIHYDROCHLORIDE
(FR) POLYMORPHE DE DICHLORHYDRATE DE LATREPIDINE
front page image
Abstract
(EN) The specification relates to a crystalline Latrepirdine dihydrochloride, Form DMB-I, method of its preparation, pharmaceutical composition containing it and its uses.
(FR) L'invention concerne un dichlorhydrate de latrepirdine cristallin, la forme DMB-I, son procédé de préparation, une composition pharmaceutique le contenant et ses utilisations.
Latest bibliographic data on file with the International Bureau
# -